TMPRSS6 Inhibition with a Monoclonal Antibody Improves Red Blood Cell Health and Reduces Hepatic Iron Loading in Mouse Models of Iron Overload Diseases

海西定 TMPRSS6 内分泌学 内科学 红细胞生成 无效红细胞生成 血色病 生物 铁转运蛋白 贫血 医学 生物化学 丝氨酸蛋白酶 蛋白酶
作者
Heinrich E. Lob,L. R. Ivanova,Beth Crowell,Hyonjong Kim,Vincent Idone,Aris N. Economides,Sarah Hatsell
出处
期刊:Blood [Elsevier BV]
卷期号:140 (Supplement 1): 8178-8178
标识
DOI:10.1182/blood-2022-162702
摘要

Beta-thalassemia is a genetic disorder arising from loss of function mutations in the beta-globin gene, leading to ineffective erythropoiesis and organ iron overload. The latter contributes to liver fibrosis, type-2 diabetes, cancer, and cardiac toxicities. The major cause of increased iron loading is the reduced hepcidin levels because of the ineffective erythropoiesis. Iron is regulated by the hormone hepcidin. The BMP6-HJV signaling axis induces hepcidin expression via SMAD1/5 activation and the serine-protease TMPRSS6 is a negative regulator of HJV. Individuals with loss-of-function mutations in the TMPRSS6 gene have high levels of circulating hepcidin resulting in iron-restricted/iron-deficiency anemia. Thus, blocking TMPRSS6 may be a viable strategy to elevate hepcidin and reduce iron levels in beta-thalassemia or hereditary hemochromatosis. We generated a monoclonal antibody (REGN7999) that inhibits TMPRSS6 activity hence preventing HJV cleavage. This in turn accentuates BMP6-HJV signaling, consequently increasing serum hepcidin. In the Hbbth3/+ mouse model of beta-thalassemia, treatment with REGN7999 (10 mg/kg, s.c., weekly for 8 weeks) led to a significant reduction in liver iron (~50% reduction compared to the isotype treated group) and improved red blood cell health as determined by Annexin V staining, intracellular oxidative stress, and measurement of red blood cell turnover. This effect on red blood cells was reflected by a longer running distance of Hbbth3/+ mice during forced exercise and a reduction in serum lactate production. Our data shows, that targeting TMPRSS6 has significant advantages over current treatments, such as Luspatercept, an ACVR2b receptor trap or iron chelation. These therapeutics target either red blood cell formation (Luspatercept) or iron loading (iron chelators), but not both. Hence, blockade of TMPRSS6 seems a good addition to current therapeutics. In addition, we tested REGN7999 in HFE-/-mice, a mouse model of hereditary hemochromatosis. After 8 weeks treatment, liver iron from HFE-/- mice was significantly reduced in these animals. Taken together, inhibition of TMPRSS6 is an advantageous strategy in different iron overload diseases.
最长约 10秒,即可获得该文献文件

科研通智能强力驱动
Strongly Powered by AbleSci AI
科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
轻松雨旋发布了新的文献求助20
刚刚
1秒前
犀牛发布了新的文献求助10
1秒前
091完成签到 ,获得积分10
1秒前
Viviiviii完成签到,获得积分10
1秒前
2秒前
2秒前
3秒前
xs小仙女完成签到 ,获得积分10
3秒前
4秒前
aaa完成签到 ,获得积分10
4秒前
5秒前
冰冰完成签到 ,获得积分10
5秒前
cloud完成签到,获得积分10
7秒前
刘帅完成签到,获得积分10
8秒前
neocc123完成签到 ,获得积分10
8秒前
52pry发布了新的文献求助10
9秒前
9秒前
dreamode发布了新的文献求助15
10秒前
strug783发布了新的文献求助10
10秒前
科研通AI2S应助Viviiviii采纳,获得10
11秒前
dada完成签到,获得积分10
11秒前
高兴的彩虹完成签到,获得积分10
12秒前
111111应助谦让的寄凡采纳,获得10
15秒前
锌小子完成签到,获得积分10
17秒前
17秒前
18秒前
lanxinge发布了新的文献求助20
18秒前
TYM发布了新的文献求助10
21秒前
小库的咖喱完成签到,获得积分20
23秒前
25秒前
nzhou2527发布了新的文献求助10
31秒前
科研通AI5应助秋子采纳,获得10
32秒前
雪sung发布了新的文献求助10
34秒前
搜集达人应助疯狂的荟采纳,获得10
36秒前
orixero应助科研通管家采纳,获得20
36秒前
隐形曼青应助科研通管家采纳,获得10
36秒前
HEIKU应助科研通管家采纳,获得10
37秒前
HEIKU应助科研通管家采纳,获得10
37秒前
ding应助科研通管家采纳,获得10
37秒前
高分求助中
【此为提示信息,请勿应助】请按要求发布求助,避免被关 20000
Encyclopedia of Geology (2nd Edition) 2000
Maneuvering of a Damaged Navy Combatant 650
Периодизация спортивной тренировки. Общая теория и её практическое применение 310
Mixing the elements of mass customisation 300
the MD Anderson Surgical Oncology Manual, Seventh Edition 300
Nucleophilic substitution in azasydnone-modified dinitroanisoles 300
热门求助领域 (近24小时)
化学 材料科学 医学 生物 工程类 有机化学 物理 生物化学 纳米技术 计算机科学 化学工程 内科学 复合材料 物理化学 电极 遗传学 量子力学 基因 冶金 催化作用
热门帖子
关注 科研通微信公众号,转发送积分 3780310
求助须知:如何正确求助?哪些是违规求助? 3325580
关于积分的说明 10223667
捐赠科研通 3040766
什么是DOI,文献DOI怎么找? 1668988
邀请新用户注册赠送积分活动 798962
科研通“疑难数据库(出版商)”最低求助积分说明 758648